Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-09 SEIDENBERG BETH C Director Other disposition −247,446 17,162
2023-06-09 SEIDENBERG BETH C Director Other acquisition +6,656 25,926
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +16,000 $3.95 $63K 231,924
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −10,131 $40.61 $411K 221,793
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,869 $41.59 $244K 215,924
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,533 $40.61 $103K 18,064
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,467 $41.59 $61K 16,597
2023-06-07 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −16,000 795,556
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +16,000 $3.95 $63K 231,924
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −7,514 $40.65 $305K 224,410
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −8,486 $41.32 $351K 215,924
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,879 $40.65 $76K 22,718
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,121 $41.32 $88K 20,597
2023-06-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −16,000 811,556
2023-06-05 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +41,666 $0.91 $38K 115,153
2023-06-05 Schlanger David J Executive Chairman Sale 10b5-1 −9,530 $39.21 $374K 105,623
2023-06-05 Schlanger David J Executive Chairman Sale 10b5-1 −32,136 $40.24 $1.3M 73,487
2023-06-05 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −41,666 357,228
2023-06-05 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +16,000 $3.95 $63K 231,924
2023-06-05 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −3,629 $39.19 $142K 228,295

Page 21 of 77 · 1,524 trades